Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03731052 · ClinicalTrials.gov registry record · Phase 3
Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
A Phase 3 study, sponsored by Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 217
- Enrollment target
NCT03731052 is a Phase 3 study that has completed, run by Therapeutics. The registered enrollment target is 217 participants.
The verdict
NCT03731052, a Phase 3 study, has completed, sponsored by Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 217 participants
- Enrollment target
Study Summary
This Phase 3 study (Study 307) has been designed to determine and compare the efficacy and safety of 188-0551 Spray and Vehicle Spray applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Spray or Vehicle Spray) to all psoriasis plaques within the designated Treatment Area twice daily for four weeks (Study Day 29), unless the investigator verifies the subject's psoriasis has cleared at Day 15, then test article application will be for 2 weeks (Study Day 15).
Interventions
- DRUG Vehicle Spray
- DRUG 188-0551 Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2019-12-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03731052
The ClinicalTrials.gov registry entry for NCT03731052 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Therapeutics, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Spray is the first listed.
NCT03731052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03731052 about?
NCT03731052 is a clinical study titled "Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)". This Phase 3 study (Study 307) has been designed to determine and compare the efficacy and safety of 188-0551 Spray and Vehicle Spray applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Spray or Vehicle Spray) to...
What is the current status of trial NCT03731052?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 217 participants. The study started on 2018-10-16. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT03731052?
The interventions under investigation include: Vehicle Spray (DRUG), 188-0551 Spray (DRUG).
Who is sponsoring clinical trial NCT03731052?
This trial is sponsored by Therapeutics, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.